Algert Global LLC Immatics N.V. Transaction History
Algert Global LLC
- $4.04 Billion
- Q1 2025
A detailed history of Algert Global LLC transactions in Immatics N.V. stock. As of the latest transaction made, Algert Global LLC holds 70,668 shares of IMTX stock, worth $413,407. This represents 0.01% of its overall portfolio holdings.
Number of Shares
70,668
Previous 58,596
20.6%
Holding current value
$413,407
Previous $417,000
23.5%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding IMTX
# of Institutions
82Shares Held
91.5MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$85.9 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$54.9 Million1.77% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.14MShares$53.4 Million1.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$50.2 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$42.6 Million0.39% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $446M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...